, p = 0.01). Multivariate logistic regression analysis proved that pulmonary hypertension (OR = 13.7, p = 0.03), male gender (OR = 10.4, p = 0.00002) 
Introduction
Sudden cardiac death (SCD), mostly resulting from ventricular arrhythmia, remains a cause of mortality in 19-30% of adults with congenital heart defects [1] [2] [3] [4] [5] . Such dramatic events in this relatively young population prompt to investigate indications for implantable cardioverter-defibrillator (ICD) therapy in primary prophylaxis. The mechanisms leading to ventricular arrhythmia in these patients are still under research. However, ventricular arrhythmia is considered to result from myocardial fibrosis caused by cyanosis and/or inadequate intraoperative cardioprotection, as well as scars after ventriculotomy. Moreover, hemodynamic changes leading to dilation of ventricles (or single ventricle) and a consequently increased wall stress resulting in areas of electrical inhomogeneity within myocardium also contribute to these rhythm disturbances [3] [4] [5] [6] [7] [8] . All mentioned pathological phenomena may additionally lead to heart failure which is a known cause of malignant arrhythmia and SCD per se [5, 6, 8, 9] . The decision on ICD therapy is often based on electrophysiology study which has demonstrated better prognostic value when conducted in preselected group of patients [6, 10] . Such preselection of subjects potentially endangered with SCD is performed with the use of some noninvasive methods, including a microvolt T wave alternans (MTWA) -an electrocardiographic (ECG) phenomenon displaying inhomogeneity of the myocardial repolarization process. It was proved that the inhomogeneity of the intracardiac repolarization leads to a dispersion of the depolarizing wave, re--entry phenomenon and, as a consequence, initiation of the ventricular arrhythmia [9, 11, 12] . A prognostic value of MTWA was strongly suggested among patients with ischemic and nonischemic advanced heart failure [13] [14] [15] [16] . To our knowledge, the issue of spectral MTWA has been addressed in merely 2 papers regarding pediatric population and only 1 concerning adults with congenital heart diseases (CHD) characterized by right ventricle pathology or single ventricle physiology that was conducted by our team [17] [18] [19] . Therefore, a necessity to continue this research among grown-up patients with other congenital cardiac anomalies seems undeniable.
The aim of the study was to evaluate the incidence of spectral MTWA in adults with CHD; to determine its coincidence with malignant and potentially malignant arrhythmia, as well as other clinical and demographical findings conducive to malignant arrhythmia and SCD in the study group.
Methods
The study protocol, as approved by the Ethics Committee of the University of Medical Sciences in Poznan, conformed to the ethical guidelines of the 1975 Declaration of Helsinki. Informed consent was obtained from all subjects.
The study group was selected from the population followed-up in [2010] [2011] [2012] Microvolt T wave alternans was analyzed in 204 patients during treadmill test while receiving their usual medications, including b-blocker therapy [12] . High-resolution electrodes (Micro-V Alternans Sensors, Cambridge Heart Inc.) were applied using Frank orthogonal configuration. MTWA was recorded during a heart rate (HR)--based exercise protocol using CH2000 (Cambridge Heart Inc., Bedford, MA, USA) using spectral method [11] . The test was considered positive if the significant MTWA (i.e. alternans voltage ≥ 1.8 μV and alternans ratio > 3.0) appeared at an onset HR £ 110 bpm, was present for ≥ 1 min in any orthogonal lead or 2 adjacent precordial leads and sustained as long as HR remained above the patient specific onset HR. The test was classified as negative if sustained MTWA was absent at HR £ 110 bpm and if there was ≥ 1 min at HR ≥ 105 bpm of artifact-free trace (noise level < 1.8 μV, ectopy < 10%). Otherwise, the test was considered indeterminate and immediately repeated in order to reduce the number of such results. As generally accepted [12] , the indeterminate test may be caused either by patient factors (including: 1) excessive ectopy during exercise, 2) unsustained MTWA, 3) failure to achieve HR = 105 bpm) or technical factors (including: 1) a noisy recording, 2) failure to maintain HR between 105 and 110 bpm for ≥ 1 min). The indeterminate results due to technical factors obtained in 25 patients were ultimately excluded from further analysis, as a consequence the analysis was performed in 179 subjects. Considering the similar prognostic significance, all tests classified as positive or indeterminate due to patient factors were combined into a common group labeled 'nonnegative' [MTWA (non-)], i.e. abnormal. The analysis of MTWA results and statistical calculations were performed by the researchers blinded to all ECG, clinical and laboratory findings.
Echocardiography was performed with VIVID 7 GE Medical System device, using 1.5-2.5 Hz probe in 2-dimensional, M-and Doppler modes. The diagnoses of anatomical anomalies were set according to the current recommendations of the European Society of Cardiology (ESC) [7] . As in other studies [20] , the diagnosis of pulmonary arterial hypertension was based on echocardiography. The estimation of pulmonary arterial pressure (PAP) was based on the peak velocity of the jet of tricuspid regurgitation enabling to calculate right ventricular systolic pressure (using Bernoulli equation). After excluding pulmonary stenosis, PAP was calculated as the sum of right ventricular systolic pressure and right atrial pressure (estimated as 5-15 mm Hg depending on the diameter and respiratory variation of the inferior vena cava). According to the current guidelines we considered the criterion of estimated PAP ≥ 37 mm Hg combined with additional echocardiographic variables suggestive of pulmonary arterial hypertension a sufficient basis to set this diagnosis [20] .
The cardiopulmonary exercise treadmill test was performed according to the modified Bruce protocol (adding stage 0-3 min, 1.7 km/h, 5% grading) and was symptom limited. The equipment was calibrated with a standard gas mixture before each test. Patients were encouraged to continue the exercise until the respiratory exchange ratio (RER) exceeded 1. Oxygen uptake (peakVO 2 ), carbon dioxide production (VCO 2 ) and minute ventilation were measured with breath by breath technique using Sensor Medics, model V max 29. PeakVO 2 was defined as the average for the last 20 s of exercise and expressed as [mL/kg/min] and [mL/min], as well as the percentage ranges predicted for sex, age, height and weight [21] . A ventilation/ /carbon dioxide slope (VE/VCO 2 slope) was assessed by linear regression for the whole exercise. A standard 12-lead ECG was continuously recorded. Due to physical disability a cardiopulmonary test was not performed in 3 patients.
Ambulatory 24-hour ECG monitoring was registered on the same day as the other tests using CardioScan12.0 Premier, Oxford system. Additionally, all previous results of ambulatory ECG available in the patients' medical records were analyzed for presence of ventricular arrhythmia, which was classified as: excessive ventricular ectopy (ventricular premature beats -VPB ≥ 10/h), episodes of non-sustained ventricular tachycardia -nsVT (presence of ≥ 3 consecutive ventricular beats at a rate greater than 100 bpm, terminating spontaneously in less than 30 s), episodes of sustained Olga Trojnarska et al., MTWA in adults with congenital heart diseases ventricular tachycardia -VT (ventricular tachycardia greater than 30 s in duration or hemodynamically unstable) [6] . According to the classification regarding patients with structural heart disease [6] this findings were divided into two groups: potentially malignant ventricular arrhythmia (VPB > 10/h and/or nsVT) and malignant ventricular arrhythmia (VT). For the purposes of analysis, a group comprising of patients with any of the specified forms of ventricular arrhythmia was formed and labeled 'VT/nsVT/VPB > 10/h'.
QRS duration was adopted as the longest value measured among all 12 leads in standard ECG.
Serum B-type natriuretic peptide (BNP) level was measured in the venous blood samples taken after 15 min of rest in supine position using the Abbott AxSYM Immunoassay system.
Statistical analysis
Continuous variables were summarized by mean ± SD or median and minimal-maximal values, depending on normality of distribution assessed with Shapiro-Wilk test. Variables following normal distribution were analyzed using Student's t test or Welch test, otherwise non-parametrical U Mann-Whitney test comparing the two groups was performed. Categorical variables are represented by frequencies and percentages and calculated as c 2 test with Yates's correction or Fisher's exact test. Factors associated with non-negative MTWA were assessed by linear logistic regression. P < 0.05 were considered statistically significant.
Results
The incidence of MTWA (+), MTWA (ind), as well as MTWA (non-) in the study group was significantly higher than among the controls (Table 2) .
Comparison between the subgroups with different MTWA results demonstrated male predominance among MTWA (+) and MTWA (non-) patients in contrast to MTWA (-) group. Subjects with MTWA (non-) manifested heart failure symptoms -NYHA > I significantly more often when compared to MTWA (-) subgroup. Blood saturation was higher in MTWA (-) patients than in subgroups with MTWA (+) and MTWA (non-). Pulmonary hypertension was also less common in MTWA (-) group when compared to MTWA (+) and MTWA (non-) ( Table 3) .
As shown in Table 4 the incidence of malignant (VT) and potentially malignant (nsVT/VPB > 10/h) arrhythmia as well as any specified form of ventricular arrhythmia (VT/nsVT/VPB > 10/h) was significantly higher in subjects with MTWA (non-) as compared to MTWA (-).
The cardiopulmonary test revealed significantly lower values of peak oxygen consumption (VO 2 , [mL/kg/min]) in MTWA (+) and MTWA (non-) subgroups than in MTWA (-) patients. Similar differences were observed in percentage values of maximal predicted oxygen consumption (%VO 2 , [mL/kg/min]), as well as %VO 2 [L/min]. Patients demonstrated a higher ventilation/carbon dioxide index -VE/VCO 2 slope and higher serum BNP concentration compared to those with MTWA (-) ( Table 5) .
As shown in univariate linear logistic regression analysis, the factors increasing probability of abnormal MTWA were: pulmonary hypertension, sustained ventricular arrhythmia, as well as any specified form of ventricular arrhythmia, male gender, NYHA > I, increased VE/VCO 2 
Discussion
A positive MTWA test was obtained in 17.3% of the analyzed patients, whereas an indeterminate result was obtained in 15.6% of them. Both of these values are significantly higher than among healthy subjects with one positive test (2.3% of the group) and none indeterminate MTWA result [22] . The incidence of MTWA (+) observed by us was comparable to the values obtained in our previous study regarding adults with congenital defect characterized by the right ventricle pathology or univentricular heart, where the incidence of positive, as well as indeterminate MTWA accounted for 17.6% each. As far as pediatric CHD population is concerned, Alexander et al. [17] described this phenomenon in 14% of patients, whereas Cheung et al. [18] described it in 14.2% of children after tetralogy of Fallot repair.
There is, however, a great difference between the results obtained by our team and the trials conducted on patients with advanced ischemic/ /nonischemic heart failure, in which the incidence of MTWA (+) reached 37-52% [13] [14] [15] [16] . Although not all researchers confirmed the prognostic value of the MTWA phenomenon, the analysis of numerous studies demonstrated its significant diagnostic role excluding the probability of SCD [10] [11] [12] 15] . On the other hand, positive and indeterminate MTWA results were proved to have similar prognostic value, therefore being qualified together as non--negative (abnormal) [10, [13] [14] [15] [16] . The abnormal MTWA was seen in 32.9% of our patients, which Table 4 . Differences in ventricular arrhythmia incidence between the subgroups defined by microvolt T-wave alternans (MTWA) result. Olga Trojnarska et al., MTWA in adults with congenital heart diseases was significantly less than the values presented in studies quoted above regarding ischemic and nonischemic heart failure (67-73% of patients). It is presumably the younger age of our patients, who were mostly in their forties, whereas subjects enrolled in the mentioned trials reached their 6 th or 7 th decade of life, that contributed to such a difference in MTWA incidence. Moreover, the functional status of our congenital heart diseases patients was also much better, with 85% being in NYHA class I.
Our study showed that a previous history of malignant and potentially malignant arrhythmia was significantly more frequent in patients with abnormal MTWA compared with the MTWA (-) group. However, the we did not confirm the relationship of that arrhythmia reported in the past with abnormal MTWA, which is congruent with the outcome of the analysis conducted in pediatric CHD population [17] .
Although the ESC and AHA experts [6, 9] recommend ambulatory ECG monitoring as OR -odds ratio; CI -confidential interval; VT -sustained ventricular tachycardia; VPB ≥ 10/h -excessive ventricular ectopy; nsVT -non--sustained ventricular tachycardia; NYHA -New York Heart Association; VE/VCO2slope -ventilation/carbon dioxide slope; VO2 -peak oxygen uptake on exercise, SO2 -oxygen blood saturation Table 5 . Differences in the chosen cardiopulmonary parameters and serum B-type natriuretic peptide level between the subgroups defined by microvolt T-wave alternans (MTWA) result. a method of SCD risk stratification in patients with structurally diseased hearts (which undeniably concerns our study group), the prognostic role of malignant arrhythmia episodes observed during this test has never been confirmed in the general population. It is known, however, that arrhythmia increases mortality among subjects with advanced heart failure simultaneously taking part in heart failure pathogenesis. On malignant arrhythmia risk stratification algorithm the analysis of ambulatory ECG monitoring is justifiable when combined with other clinical findings increasing this risk. A comprehensive analysis by Cutler and Rosenbaum [10] , regarding the papers published in the last decade, undeniably demonstrated an algorithm considering a few carefully combined ventricular arrhythmia risk factors in patients with ischemic or nonischemic cardiomyopathy to enable more accurate qualification for ICD in primary prevention of SCD, exceeding even outcomes of implantations made in secondary prophylaxis. It seems reasonable to apply these rules also in CHD population. Therefore, we expanded the analysis to determine which demographical and clinical findings of possible prognostic value for SCD are observed in subjects with abnormal MTWA. The association between a patient's age and MTWA result was not confirmed, although in the general population the risk of SCD increases significantly after the age of 35 [6] . In the analyzed subjects who have been affected with the disease since birth, it is rather the severity of a given defect that worsens a patient's prognosis. Also the fact of undergoing potentially beneficial cardio--surgery turned out to have no prognostic value, as repairs are usually performed in advanced cardiac anomalies and remaining scars may be the origin of arrhythmia [1] [2] [3] [4] [5] . Our study showed in turn the predominance of males among MTWA (non-) patients with male gender being also a factor that increases the probability of this phenomenon. This confirms the observation that men die more often due to SCD than women [6] . In the CHD population male gender was proved to be a risk factor of life-threatening arrhythmia [23, 24] , as well as of total mortality [2] .
Patients
Our study demonstrated worse exercise tolerance in patients with abnormal MTWA when compared to the MTWA (-) group and their functional status was more often impaired (NYHA > I). It is proved that deterioration in NYHA classification has an adverse prognostic value for SCD in patients with congenital heart anomaly [7, 25, 26] . This association might be due to the heart failure--related hypercatecholaminemia that increases the risk of ventricular arrhythmia, simultaneously confirming the rationale for including MTWA into SCD risk stratification in the analyzed population [27] . However, our study neither proved higher NYHA class nor higher serum BNP concentration to increase the probability of abnormal MTWA. We confirmed the prognostic value of cardiopulmonary parameters: ventilation-carbon dioxide production relationship (VE/VCO 2 slope) and peak oxygen consumption (VO 2 [mL/kg/min]). A predictive role of the latter parameter for ventricular arrhythmia in CHD population was also proved by other authors [23] .
Other factors contributing to heart failure pathogenesis in patients with that heart anomaly are elevated pulmonary and decreased blood saturation, often coexisting, hence difficult to be analyzed separately [26, 27] . We observed these 2 clinical features more often in patients with abnormal MTWA, though only pulmonary hypertension was confirmed to increase the probability of this phenomenon. Sub-pulmonary ventricle pressure overload along with cyanosis-related tissue hypoxia, as well as segmental dilation and tortuosity of the coronary arteries typical for increased blood viscosity lead to the myocardial fibrosis creating a substrate for ventricular arrhythmia [28, 29] .
Similarly to the general cardiologic population [13] [14] [15] [16] , among patients with CHD the abnormal MTWA was observed more frequent in those with advanced heart failure, already proved to be linked to ventricular arrhythmia. The parameters determining the cardiac impairment in this anatomically diversified population turned out to be the factors increasing probability of non-negative MTWA. Although the unquestionable relationship between this phenomenon and malignant or potentially malignant arrhythmia was not stated, the obtained results give the rationale for applying MTWA test in SCD risk stratification algorithm for CHD patients. Further studies are required to confirm the value of this diagnostic tool.
Limitations of the study
The main methodological limitations of our study are the lack of prospective analysis and the limited number of patients. A smaller group size than in ischemic and nonischemic heart failure trials is characteristic for this unique population and is seen in the majority of CHD studies. The number of patients, as well as the incidence of potential end points determine the follow-up period, which, according to the statistical rules, should last more than 10 years and has been already started by our team [8, 30] .
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Conclusions
The incidence of abnormal MTWA among patients with congenital heart defects is higher than in healthy subjects. The probability of this phenomenon increases in patients with clinical findings possibly conducive to lethal arrhythmia including heart failure and pulmonary hypertension, as well as in males. The confirmation of MTWA potential role in SCD risk stratification in this population requires further investigation.
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